Online citations, reference lists, and bibliographies.
← Back to Search

Hypertension After Renal Transplantation.

C. Ponticelli, G. Montagnino, A. Aroldi, C. Angelini, M. Braga, A. Tarantino
Published 1993 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
In 212 cyclosporine-treated renal transplant recipients with stable graft function at 1 year and with potential follow-up of 5 years the prevalence of arterial hypertension was 81.6% at 1 year and 81.2% at 5 years. The logistic regression analysis showed that the presence of hypertension before transplantation (P = 0.0001; odds ratio 3.5), a plasma creatinine level higher than 2 mg/dL at 1 year (P = 0.0001; odds ratio 3.8), and a maintenance therapy with corticosteroids (P = 0.008; odds ratio 3.3) were positively associated with hypertension at 1 year after transplantation. The mean number of graft failures between 1 and 5 years was significantly higher and the mean reciprocal of plasma creatinine was significantly worse at 1 and 5 years in patients with noncontrolled hypertension than in normotensive patients or in patients with hypertension well controlled by drugs. We also investigated the potential protective role of nifedipine. The episodes of acute tubular necrosis (four versus three), of acute rejections (28 versus 29), the mean arterial pressure at 1 year (105 +/- 9 versus 104 +/- 9 mm Hg) and 5 years (105 +/- 10 versus 108 +/- 12 mm Hg), and the mean plasma creatinine level at 1 year (1.4 +/- 0.4 versus 1.6 +/- 0.4 mg/dL) and 5 years (1.8 +/- 1 versus 1.9 +/- 1 mg/dL) were similar in 52 patients who were given nifedipine for at least 4 years and 58 hypertensive patients who never took calcium channel blockers.(ABSTRACT TRUNCATED AT 250 WORDS)
This paper references
10.1097/00007890-199107000-00011
A RANDOMIZED PROSPECTIVE TRIAL COMPARING CYCLOSPORINE MONOTHERAPY WITH TRIPLE‐DRUG THERAPY IN RENAL TRANSPLANTATION
A. Tarantino (1991)
10.1038/KI.1985.196
Effect of cyclosporine administration on renal hemodynamics in conscious rats.
B. M. Murray (1985)
Prévalence, étiologie et traitement de l'hypertension après transplantation rénale
C. V. Y. D. Strihou (1982)
10.1056/NEJM198605153142005
Renal histopathologic alterations in patients treated with cyclosporine for uveitis.
A. Palestine (1986)
10.1056/NEJM199009133231101
Cyclosporine-induced sympathetic activation and hypertension after heart transplantation.
U. Scherrer (1990)
Verapamil prevents post-transplant oliguric renal failure.
K. Duggan (1985)
10.1001/ARCHINTE.1978.03630330036011
Relationship of renal transplantation to hypertension in end-stage renal failure.
T. K. Sreepada (1978)
10.1016/0002-9149(85)90406-0
Systemic hypertension after cardiac transplantation: effect of cyclosporine on the renin-angiotensin-aldosterone system.
M. Bellet (1985)
10.1097/00007890-199110000-00012
IMPROVED OUTCOME OF CADAVERIC RENAL TRANSPLANTATION DUE TO CALCIUM CHANNEL BLOCKERS
B. Palmer (1991)
10.1097/00007890-199012000-00036
A prospective study of prophylactic ATG versus cyclosporine in regrafted and highly sensitized renal allograft recipients.
R. C. Pearson (1990)
10.1097/00007890-198711000-00009
POSSIBLE CAUSES AND CONSEQUENCES OF HYPERTENSION IN STABLE RENAL TRANSPLANT PATIENTS
B. Kasiske (1987)
10.1056/NEJM198302173080707
Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension.
J. Curtis (1983)
10.1136/BMJ.295.6602.851-B
Does nifedipine ameliorate cyclosporin A nephrotoxicity?
J. Kwan (1987)
10.1159/000167487
Prevention of posttransplant acute tubular necrosis by the calcium antagonist diltiazem: a prospective randomized study.
K. Wagner (1987)
10.1016/0022-4804(85)90164-7
Verapamil inhibition of lymphocyte proliferation and function in vitro.
M. Mcmillen (1985)
10.1097/00007890-198805000-00014
A RANDOMIZED TRIAL COMPARING TRIPLE‐DRUG AND DOUBLE‐DRUG THERAPY IN RENAL TRANSPLANTATION
C. Ponticelli (1988)
Interaction between cyclosporine and felodipine in renal transplant recipients.
E. Pedersen (1992)
Prevention of acute cyclosporine-induced renal blood flow inhibition and improved immunosuppression with verapamil.
I. Dawidson (1989)
10.1080/00401706.1991.10484817
Categorical Data Analysis
A. Agresti (1991)
10.1093/AJH/4.5.468
Mechanism of cyclosporine-induced hypertension.
R. Luke (1991)
10.1093/NDT/5.12.1038
Additive effects of calcium antagonists on cyclosporin A-induced inhibition of T-cell proliferation.
M. Marx (1990)
10.1097/00007890-198912000-00014
Cyclosporine-induced renal dysfunction in human renal allograft recipients.
B. Kiberd (1989)
10.1042/CS0810271
Influence of nifedipine on cyclosporin A nephrotoxicity after unilateral nephrectomy in the spontaneously hypertensive rat.
P. Mcnally (1991)
10.1016/0002-9343(84)90356-5
Side effects of systemic cyclosporine in patients not undergoing transplantation.
A. Palestine (1984)
10.1016/S0140-6736(86)90355-7
CYCLOSPORIN IN THERAPEUTIC DOSES INCREASES RENAL ALLOGRAFT VASCULAR RESISTANCE
J. Curtis (1986)
10.1097/00007890-199102000-00002
Evidence that calcium channel blockade prevents cyclosporine-induced exacerbation of renal ischemic injury.
M. Bia (1991)
10.1097/00007890-199108000-00018
Effects of diltiazem upon metabolism and immunosuppressive action of cyclosporine in kidney graft recipients.
U. Kunzendorf (1991)
10.1136/BMJ.295.6593.310
Does nifedipine ameliorate cyclosporin A nephrotoxicity?
J. Feehally (1987)



This paper is referenced by
10.1016/S0022-5347(01)65166-8
Laparoscopic bilateral nephrectomy: results in 11 renal transplant patients.
P. Fornara (1997)
Chronisches Transplantatversagen - Einfluss der arteriellen Hypertonie auf die Langzeitfunktion nach Nierentransplantation
Abteilung für Innere Medizin (2007)
Hipertensión arterial postrasplante renal: factores de riesgo asociados e influencia en la supervivencia del injerto renal
A. Chew-Wong (2005)
Losartan versus Valsartan in the treatment of hypertension of renal transplant recipients
G. Vergoulas (2001)
10.1007/978-94-007-1031-3_20
Blood pressure management in the dialysis patient
J. Samuels (2004)
10.1016/S0041-1345(98)01284-6
Hypertension in kidney transplantation recipients: effect on long-term renal allograft survival.
H. Kim (1998)
10.2174/157340207779815545
Hypertension in Children After Renal Transplantation
T. Seeman (2007)
10.1016/J.TRIM.2006.10.001
The aetiology and pathogenesis of chronic allograft nephropathy.
P. Yates (2006)
10.1016/S0041-1345(98)01124-5
Ten years after: long-term effects of cyclosporine-based immunosuppression on renal allograft recipients.
T. Kondo (1998)
10.1097/00007890-199702150-00002
Treatment of hyperlipidemia in renal transplant recipients.
M. Árnadóttir (1997)
10.1016/j.transproceed.2012.01.111
Assessment of cardiovascular risk factors after renal transplantation: a step towards reducing graft failure.
R. Kumar (2012)
10.5301/jn.5000237
Relationship between hemorheology and endothelial dysfunction in renal transplant patients receiving calcineurin inhibitors.
H. Akoğlu (2013)
10.1007/s11906-001-0063-1
Hypertension after renal transplantation
V. Schwenger (2003)
10.1016/j.atherosclerosis.2009.05.025
Role of rho-kinase in the regulation of vascular tone in hypertensive renal transplant recipients.
E. Büssemaker (2009)
10.1016/S0828-282X(09)70495-7
Hypertension in dialysis and kidney transplant patients.
G. V. Prasad (2009)
Does hypertension remain after kidney transplantation?
G. Pourmand (2015)
10.1016/S0272-6386(99)70253-2
Early immunologic and nonimmunologic predictors of arterial hypertension after renal transplantation.
M. Pérez Fontán (1999)
10.1007/978-1-60327-362-6_25
Drug–Nutrient Interactions in Transplantation
M. Weiss (2009)
10.1016/S0272-6386(00)70302-7
ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy.
C. Stigant (2000)
10.1016/j.vph.2019.02.002
Drug-induced hypertension: Know the problem to know how to deal with it.
S. Masi (2019)
10.1007/S001470050358
Conversion from cyclosporine A to tacrolimus after kidney transplantation due to hyperlipidemia
M. Kohnle (2000)
10.1016/S0022-3476(03)00209-9
Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients.
M. Mitsnefes (2003)
10.1016/j.trre.2018.06.002
Hypertension guidelines: How do they apply to kidney transplant recipients.
F. Aziz (2018)
10.1093/NDT/13.8.2092
Role of the peripheral renin profile in predicting blood pressure control after bilateral nephrectomy in renal-transplanted patients.
M. C. Teixeira (1998)
10.1038/KI.1995.162
Racial differences in renal allograft survival: the role of systemic hypertension.
F. Cosio (1995)
10.1016/J.CQN.2013.08.002
Hypertension in renal transplantation
Ravi K. Sharma (2013)
Hypertension arterielle après transplantation rénale : Influence du profil tensionnel au stade de dialyse
I. Mpio (1997)
10.1007/S001470050416
Hypertension accelerates the pace of chronic graft dysfunction in the rat
A. Szabó (1998)
10.1016/j.brainres.2008.11.008
Interruption of central neuronal pathway of imidazoline I1 receptor mediates the hypertensive effect of cyclosporine in rats
M. M. El-Mas (2009)
10.3109/9781420016666-22
Medical Complications Following Pancreas Transplantation
R. Corry (2006)
10.1016/S1889-1837(02)71231-2
Hipertensión arterial después del trasplante renal
B. Domínguez-Gil (2002)
10.1007/S001470050721
Etiology and pathophysiology of chronic transplant dysfunction
Ewout A. Kouwenhoven (2000)
See more
Semantic Scholar Logo Some data provided by SemanticScholar